Monopar Therapeutics

MNPR

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001645469

SEC filings (opens in a new tab)

In the last 90 days, Monopar Therapeutics insiders filed 0 open-market purchases and 4 sales; 95 institutions reported holding it in 13F filings for Q2 2026, worth $576.1M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Monopar Therapeutics changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of MNPR: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	82	2	95	+15
Shares	6.24M	1.32M	6.22M	+1.30M (+26.5%)
Value	$341.5M	$72.1M	$576.1M	+$306.7M (+113.8%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Monopar Therapeutics at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to MNPR in Q2 2026
Institution	Shares	Value	% of portfolio
Jupiter Topco LLC	1,312,129	$121.7M	0.05%
OrbiMed Advisors LLC	157,423	$14.6M	0.28%
Candriam Luxembourg S.C.A.	143,339	$13.3M	0.06%
Longaeva Partners L.P.	55,834	$5.17M	0.15%
Ikarian Capital, LLC	47,861	$4.43M	0.73%
StemPoint Capital LP	30,125	$2.79M	0.48%
Boothbay Fund Management, LLC	14,689	$1.36M	0.03%
Ishara Investments LP	12,300	$1.14M	0.85%
Trexquant Investment LP	12,004	$1.11M	0.01%
Gsa Capital Partners LLP	7,532	$697.0K	0.04%
XTX Topco Ltd	6,536	$605.2K	0.01%
Raymond James Financial Inc	5,474	$506.8K	0.00%
State Board of Administration of Florida Retirement System	5,300	$490.7K	0.00%
Aquatic Capital Management LLC	3,827	$354.3K	0.01%
Alliancebernstein L.P.	4,760	$260.8K	0.00%
EP Wealth Advisors, LLC	2,603	$241.0K	0.00%
Entropy Technologies, LP	2,600	$240.7K	0.01%
Gabelli Funds LLC	2,500	$231.5K	0.00%
American Century Companies Inc	2,469	$228.6K	0.00%
Invesco Ltd.	2,356	$218.1K	0.00%
Martin Investment Management, LLC	2,327	$215.5K	0.07%
Schonfeld Strategic Advisors LLC	2,310	$213.9K	0.00%
Quarry LP	1,502	$139.1K	0.02%
Northwestern Mutual Wealth Management Co	1,350	$125.0K	0.00%
C M Bidwell & Associates Ltd	94	$8.70K	0.00%
Global Retirement Partners, LLC	32	$2.96K	0.00%
Farther Finance Advisors, LLC	24	$2.22K	0.00%
The PNC Financial Services Group, Inc.	6	$556	0.00%
SRS Capital Advisors, Inc.	3	$278	0.00%

Sold out (14)

Institutions that held Monopar Therapeutics at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of MNPR in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Sio Capital Management, LLC	173,506	$9.51M
Walleye Capital LLC	63,119	$3.46M
Silverarc Capital Management, LLC	43,488	$2.38M
Jump Financial, LLC	22,808	$1.25M
Squarepoint Ops LLC	21,754	$1.19M
SEI Investments Co	7,582	$415.4K
EAM Investors, LLC	6,225	$341.1K
TD Asset Management Inc	5,884	$322.4K
Manufacturers Life Insurance Company, The	4,572	$250.5K
Susquehanna International Group, LLP	4,137	$226.7K
Quadrature Capital Ltd	3,673	$201.2K
Your Advocates Ltd., LLP	3,344	$183.2K
Caitong International Asset Management Co., Ltd	25	$1.37K
Kilter Group LLC	1	$55

Not filed for Q2 2026 yet (2)

Institutions that held Monopar Therapeutics at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MNPR in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Janus Henderson Group PLC	1,317,410	$72.1M
CWM, LLC	15	$822